For the Inventor, By the Inventor

Enter assignee name

Menlo Park, CA, United States of America

Virobay, Inc.

USPTO Granted Patents = 22

% Expired Patents = 31.8

CIPO Patents = 1

EPO Patents = 8

Forward Citations = 33

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

John O Link (13 out of 99 patents)

Michael Graupe (7 out of 76 patents)

Soon Hyung Woo (7 out of 12 patents)

4. Craig J Mossman (6 out of 8 patents)

5. Michael G Roepel (4 out of 7 patents)

6. Jie Liu (3 out of 29 patents)

7. Chandrasekar Venkataramani (2 out of 61 patents)

8. Jeffrey Dener (2 out of 2 patents)

9. Leslie Jean Holsinger (2 out of 4 patents)

10. Sheila M Zipfel (1 out of 45 patents)

11. In Jong Kim (1 out of 44 patents)

12. Robert Booth (1 out of 4 patents)

13. Jie Liu (1 out of 53 patents)

14. Jiayao Li (1 out of 25 patents)

15. Randall W Vivian (1 out of 23 patents)

22 patents: Sort by Forward Citations

1. 8748649 - Di-fluoro containing compounds as cysteine protease inhibitors (2014-06-10),

2. 8680152 - Cathepsin inhibitors for the treatment of bone cancer and bone cancer pain (2014-03-25),

3. 8518874 - HCV inhibitors (2013-08-27),

4. 8450373 - Alpha ketoamide compounds as cysteine protease inhibitors (2013-05-28),

5. 8431733 - Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives (2013-04-30),

6. 8367732 - Di-fluoro containing compounds as cysteine protease inhibitors (2013-02-05),

7. 8324417 - [object Object] (2012-12-04),

8. 8211897 - Inhibitors of cathepsin B (2012-07-03),

9. 8163735 - Sulfonamide compounds as cysteine protease inhibitors (2012-04-24),

10. 8143448 - Process for the preparation of (3S)-3-amino-N-cyclopropyl-2-hydroxyalkanamide derivatives (2012-03-27),

11. 8106059 - Substituted pyrazines that inhibit protease cathepsin S and HCV replication (2012-01-31),

12. 8013186 - Haloalkyl containing compounds as cysteine protease inhibitors (2011-09-06),

13. 8013183 - Alpha ketoamide compounds as cysteine protease inhibitors (2011-09-06),

14. 7893112 - Di-fluoro containing compounds as cysteine protease inhibitors (2011-02-22),

15. 7893093 - Sulfonyl containing compounds as cysteine protease inhibitors (2011-02-22),

Virobay, Inc. is a biotechnology company focused on the discovery and development of small molecule therapeutics. Leveraging a proprietary drug discovery platform, Virobay aims to address unmet medical needs in various therapeutic areas including oncology, immunology, and rare genetic diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Sep 15 2026

22 Patents

#73 in Menlo Park, CA

#3,579 in California

#15,000 in US

#28,686 in the World

Menlo Park, CA, United States of America

Virobay, Inc.

Forward Citations = 33

23 inventors:

John O Link (13 out of 99 patents)

Michael Graupe (7 out of 76 patents)

Soon Hyung Woo (7 out of 12 patents)

4. Craig J Mossman (6 out of 8 patents)

5. Michael G Roepel (4 out of 7 patents)

Please report any incorrect information to [email protected]

Loading…